ESR1 and neoplasm: The main factors considered for initiating patients with IBC-NSTs on adjuvant or neoadjuvant chemotherapy are the tumor size, nodal status, nuclear grade, age, tumor subtype based on the results of IHC for ER, PgR, and HER2, and the Ki67 index.